introduction the global initiative for Chronic obstructive lung disease (gold) recently published an updated 2016 edition of the global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (Copd)1 the aim of the document is to guide healthcare professionals in the diagnosis and management thereof and to differentiate patients with Copd from those with a...

In chronic obstructive pulmonary disease(COPD) patients use extensively supplementary respiratory muscles such as trapezium and scalenes in order to facilitate ventilation. These situations cause pain restricting by the upper body mobility neck movements. This study was conducted investigate presence of individuals with COPD compare it healthy individuals. The included sixty-two COPD(COPD group...

Introduction: Chronic obstructive pulmonary disease (COPD) is associated with

Pulmonary hypertension in chronic obstructive pulmonary disease. J.A. Barberà, V.I. Peinado, S. Santos. #ERS Journals Ltd 2003. ABSTRACT: Pulmonary hypertension is a common complication of chronic obstructive pulmonary disease (COPD). Its presence is associated with shorter survival and worse clinical evolution. In COPD, pulmonary hypertension tends to be of moderate severity and progresses slo...

Objective(s): Yu-Ping-Feng-San (YPFS) is a classical traditional Chinese medicine that is widely used for treatment of the diseases in respiratory systems, including chronic obstructive pulmonary disease (COPD) recognized as chronic inflammatory disease. However, the molecular mechanism remains unclear. Here we detected the factors involved in transforming growth factor beta 1 (TGF-β1)/Smad2 si...

Novel therapies in chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) continues to be a major medical problem. With no curative therapy being available, management of severe exacerbations of COPD should be directed at relieving symptoms and restoring functional capacity [1]. Mortality from COPD continues to rise and the World Health Organisation predicts it will ...

Chronic obstructive pulmonary disease (COPD), the frequently fatal pathology of respiratory tract, accounts for half a billion cases globally. COPD manifests via chronic inflammatory response to irritants, tobacco smoke. The progression from early onset advanced leads loss alveolar wall, hypertension, and fibrosis epithelium. Here, we focus on epidemiology, progression, biomarkers with particul...

Abbreviations: chronic obstructive pulmonary disease, COPD; quality adjusted life years, QALYs; forced expiratory volume in 1 second, FEV1; forced vital capacity, FVC Citation: Pinnock H, Sohanpal R. Editorial-Chronic obstructive pulmonary disease: reduced nihilism, but there is still a ways to go. Chronic Obstr Pulm Dis (Miami). 2016; 3(3): 605-609. doi: http://dx.doi.org/10.15326/jcopdf.3.3.2...

phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). Pulm Pharmacol Ther 2003; 16: 341–347. 5 Hatzelmann A, Morcillo EJ, Lungarella G, et al. The preclinical pharmacology of roflumilast – a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulm Pharmaco...